JON RUSSELL: Open Payments
NPI 1942998513 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$903 in 47 payments from 12 companies in 2025. Trend: 2023 $479 · 2024 $822 · 2025 $903
Food & beverage: $903
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $222 |
| Novo Nordisk Inc | 8 | $165 |
| ABBVIE INC. | 5 | $108 |
| GlaxoSmithKline, LLC. | 4 | $86 |
| Lilly USA, LLC | 4 | $82 |
| AstraZeneca Pharmaceuticals LP | 4 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Exact Sciences Corporation | 2 | $44 |
| Amgen Inc. | 2 | $31 |
| Boston Scientific Corporation | 1 | $22 |
Products named: PREVNAR 20, MOUNJARO, Wegovy, TRELEGY ELLIPTA, NURTEC ODT, Ozempic, ELIQUIS, UBRELVY.
Industry payments across FL — which companies pay providers there.
